Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2011 (2011), Article ID 935631, 5 pages
http://dx.doi.org/10.1155/2011/935631
Review Article

Pharmacological Treatment of Neonatal Opiate Withdrawal: Between the Devil and the Deep Blue Sea

1Sydney Medical School-Nepean, The University of Sydney, Penrith, NSW 2751, Australia
2Perinatal Research Centre, UQ Centre for Clinical Research, The University of Queensland, Herston, QLD 4029, Australia

Received 8 September 2010; Revised 18 February 2011; Accepted 28 March 2011

Academic Editor: Chulathida Chomchai

Copyright © 2011 Anthony Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. O'Donnell, N. Nassar, H. Leonard et al., “Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement,” Pediatrics, vol. 123, no. 4, pp. e614–e621, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. J. Bell and L. Harvey-Dodds, “Pregnancy and injecting drug use,” British Medical Journal, vol. 336, no. 7656, pp. 1303–1305, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. K. Kaltenbach, V. Berghella, and L. Finnegan, “Opioid dependence during pregnancy: effects and management,” Obstetrics and Gynecology Clinics of North America, vol. 25, no. 1, pp. 139–151, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Keegan, M. Parva, M. Finnegan, A. Gerson, and M. Belden, “Addiction in pregnancy,” Journal of Addictive Diseases, vol. 29, no. 2, pp. 175–191, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. Ornoy, V. Michailevskaya, I. Lukashov, R. Bar-Hamburger, and S. Harel, “The developmental outcome of children born to heroin-dependent mothers, raised at home or adopted,” Child Abuse and Neglect, vol. 20, no. 5, pp. 385–396, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. “Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs,” Pediatrics, vol. 101, no. 6, pp. 1079–1088, 1998, Erratum: “Neonatal drug withdrawal” Pediatrics, vol. 102, no. 3, p. 660, 1998.
  7. T. M. Doberczak, S. Shanzer, R. Cutler, R. T. Senie, J. A. Loucopoulos, and S. R. Kandall, “One-year follow-up of infants with abstinence-associated seizures,” Archives of Neurology, vol. 45, no. 6, pp. 649–653, 1988. View at Google Scholar · View at Scopus
  8. R. A. Herzlinger, S. R. Kandall, and H. G. Vaughan Jr., “Neonatal seizures associated with narcotic withdrawal,” Journal of Pediatrics, vol. 91, no. 4, pp. 638–641, 1977. View at Google Scholar · View at Scopus
  9. S. R. Kandall and L. M. Gartner, “Late presentation of drug withdrawal symptoms in newborns,” American Journal of Diseases of Children, vol. 127, no. 1, pp. 58–61, 1974. View at Google Scholar · View at Scopus
  10. C. Zelson, S. J. Lee, and M. Casalino, “Neonatal narcotic addiction. Comparative effects of maternal intake of heroin and methadone,” New England Journal of Medicine, vol. 289, no. 23, pp. 1216–1220, 1973. View at Google Scholar · View at Scopus
  11. C. Zelson, E. Rubio, and E. Wasserman, “Neonatal narcotic addiction: 10 year observation,” Pediatrics, vol. 48, no. 2, pp. 178–189, 1971. View at Google Scholar · View at Scopus
  12. I. J. Chasnoff, R. Hatcher, and W. J. Burns, “Early growth patterns of methadone-addicted infants,” American Journal of Diseases of Children, vol. 134, no. 11, pp. 1049–1051, 1980. View at Google Scholar · View at Scopus
  13. C. Kuschel, “Managing drug withdrawal in the newborn infant,” Seminars in Fetal and Neonatal Medicine, vol. 12, no. 2, pp. 127–133, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. A. Martinez, B. Kastner, and H. William Taeusch, “Hyperphagia in neonates withdrawing from methadone,” Archives of Disease in Childhood, vol. 80, no. 3, pp. F178–F182, 1999. View at Google Scholar · View at Scopus
  15. S. M. Weinberger, S. R. Kandall, and T. M. Doberczak, “Early weight-change patterns in neonatal abstinence,” American Journal of Diseases of Children, vol. 140, no. 8, pp. 829–832, 1986. View at Google Scholar · View at Scopus
  16. L. Burns, E. Conroy, and R. P. Mattick, “Infant mortality among women on a methadone program during pregnancy,” Drug and Alcohol Review, vol. 29, no. 5, pp. 551–556, 2010. View at Publisher · View at Google Scholar · View at PubMed
  17. G. K. Hulse, E. Milne, D. R. English, and C. D. J. Holman, “Assessing the relationship between maternal opiate use and neonatal mortality,” Addiction, vol. 93, no. 7, pp. 1033–1042, 1998. View at Google Scholar · View at Scopus
  18. S. K. Lam, W. K. To, S. J. Duthie, and H. K. Ma, “Narcotic addiction in pregnancy with adverse maternal and perinatal outcome,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 32, no. 3, pp. 216–221, 1992. View at Google Scholar · View at Scopus
  19. E. M. Ostrea, A. R. Ostrea, and P. M. Simpson, “Mortality within the first 2 years in infants exposed to cocaine, opiate, or cannabinoid during gestation,” Pediatrics, vol. 100, no. 1, pp. 79–83, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. S. L. Ward, D. B. Bautista, M. S. Woo et al., “Responses to hypoxia and hypercapnia in infants of substance-abusing mothers,” Journal of Pediatrics, vol. 121, no. 5 I, pp. 704–709, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. J. G. Wingkun, J. S. Knisely, S. H. Schnoll, and G. R. Gutcher, “Decreased carbon dioxide sensitivity in infants of substance-abusing mothers,” Pediatrics, vol. 95, no. 6, pp. 864–867, 1995. View at Google Scholar · View at Scopus
  22. L. P. Finnegan, J. F. Connaughton, R. E. Kron, and J. P. Emich, “Neonatal abstinence syndrome: assessment and management,” Addictive Diseases, vol. 2, no. 1-2, pp. 141–158, 1975. View at Google Scholar · View at Scopus
  23. M. T. Crocetti, D. D. Amin, and L. M. Jansson, “Variability in the evaluation and management of opiate-exposed newborns in Maryland,” Clinical Pediatrics, vol. 46, no. 7, pp. 632–635, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. K. Johnson, C. Gerada, and A. Greenough, “Treatment of neonatal abstinence syndrome,” Archives of Disease in Childhood, vol. 88, no. 1, pp. F2–F5, 2003. View at Google Scholar · View at Scopus
  25. J. Oei and K. Lui, “Management of the newborn infant affected by maternal opiates and other drugs of dependency,” Journal of Paediatrics and Child Health, vol. 43, no. 1-2, pp. 9–18, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. J. O'Grady, J. Hopewell, and M. J. White, “Management of neonatal abstinence syndrome: a national survey and review of practice,” Archives of Disease in Childhood, vol. 94, no. 4, pp. F249–F252, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. D. A. Osborn, M. J. Cole, and H. E. Jeffery, “Opiate treatment for opiate withdrawal in newborn infants,” Cochrane Database of Systematic Reviews, no. 10, article CD002059, 2010. View at Google Scholar
  28. D. A. Osborn, H. E. Jeffery, and M. J. Cole, “Sedatives for opiate withdrawal in newborn infants,” Cochrane Database of Systematic Reviews, no. 10, article CD002053, 2010. View at Google Scholar
  29. S. Sarkar and S. M. Donn, “Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey,” Journal of Perinatology, vol. 26, no. 1, pp. 15–17, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. NSW Department of Health, Intergovernmental Committee on Drugs, Ministerial Council on Drug Strategy, National Clinical Guidelines for the Management of Drug Use during Pregnancy, Birth and the Early Developmental Years of the Newborn, NSW Department of Health, Sydney, Australia, 2006.
  31. N. S. Seligman, N. Salva, E. J. Hayes, K. C. Dysart, E. C. Pequignot, and J. K. Baxter, “Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates,” American Journal of Obstetrics and Gynecology, vol. 199, no. 4, pp. 396.e1–396.e7, 2008. View at Publisher · View at Google Scholar · View at PubMed
  32. W. O. Farid, S. A. Dunlop, R. J. Tait, and G. K. Hulse, “The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data,” Current Neuropharmacology, vol. 6, no. 2, pp. 125–150, 2008. View at Publisher · View at Google Scholar · View at PubMed
  33. K. Kaltenbach and L. P. Finnegan, “Perinatal and developmental outcome of infants exposed to methadone in-utero,” Neurotoxicology and Teratology, vol. 9, no. 4, pp. 311–313, 1987. View at Google Scholar · View at Scopus
  34. E. K. Enters, H. Guo, U. Pandey, D. Ko, and S. E. Robinson, “The effect of prenatal methadone exposure on development and nociception during the early postnatal period of the rat,” Neurotoxicology and Teratology, vol. 13, no. 2, pp. 161–166, 1991. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Niu, B. Cao, H. Zhu et al., “Impaired in vivo synaptic plasticity in dentate gyrus and spatial memory in juvenile rats induced by prenatal morphine exposure,” Hippocampus, vol. 19, no. 7, pp. 649–657, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. L. M. Schrott, L. T. M. Franklin, and P. A. Serrano, “Prenatal opiate exposure impairs radial arm maze performance and reduces levels of BDNF precursor following training,” Brain Research, vol. 1198, no. C, pp. 132–140, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. I. Vathy, “Effects of prenatal morphine and cocaine on postnatal behaviors and brain neurotransmitters,” NIDA Research Monograph, vol. 158, pp. 88–114, 1995. View at Google Scholar · View at Scopus
  38. I. Vathy, “Prenatal opiate exposure: long-term CNS consequences in the stress system of the offspring,” Psychoneuroendocrinology, vol. 27, no. 1-2, pp. 273–283, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Wang and T. Z. Han, “Prenatal exposure to heroin in mice elicits memory deficits that can be attributed to neuronal apoptosis,” Neuroscience, vol. 160, no. 2, pp. 330–338, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. C. J. Schindler, J. Velíšková, R. Šlamberová, and I. Vathy, “Prenatal morphine exposure alters susceptibility to bicuculline seizures in a sex- and age-specific manner,” Developmental Brain Research, vol. 121, no. 1, pp. 119–122, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Vargas-Perez, R. T. A. Kee, C. H. Walton et al., “Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naïve rats,” Science, vol. 324, no. 5935, pp. 1732–1734, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. K. J. Meador, G. A. Baker, and N. Browning, “Cognitive functioning at 3 years of age after fetal exposure to antiepileptic drugs,” New England Journal of Medicine, vol. 360, pp. 1597–1605, 2009. View at Google Scholar
  43. S. L. Hans, “Prenatal drug exposure: behavioral functioning in late childhood and adolescence,” NIDA Research Monograph, vol. 164, pp. 261–276, 1996. View at Google Scholar · View at Scopus
  44. K. A. Kaltenbach, “Effects of in-utero opiate exposure: new paradigms for old questions,” Drug and Alcohol Dependence, vol. 36, no. 2, pp. 83–87, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. K. A. Kaltenbach, “Exposure to opiates: behavioral outcomes in preschool and school-age children,” NIDA Research Monograph, vol. 164, pp. 230–241, 1996. View at Google Scholar
  46. B. M. Lester and L. L. Lagasse, “Children of addicted women,” Journal of Addictive Diseases, vol. 29, no. 2, pp. 259–276, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. A. H. Schempf, “Illicit drug use and neonatal outcomes: a critical review,” Obstetrical and Gynecological Survey, vol. 62, no. 11, pp. 749–757, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. K. B. Walhovd, V. Moe, K. Slinning et al., “Effects of prenatal opiate exposure on brain development—a call for attention,” Nature Reviews Neuroscience, vol. 10, no. 5, p. 390, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. R. W. Hunt, D. Tzioumi, E. Collins, and H. E. Jeffery, “Adverse neurodevelopmental outcome of infants exposed to opiate in-utero,” Early Human Development, vol. 84, no. 1, pp. 29–35, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. K. Kaltenbach and L. P. Finnegan, “Developmental outcome of children born to methadone maintained women: a review of longitudinal studies,” Neurobehavioral Toxicology and Teratology, vol. 6, no. 4, pp. 271–275, 1984. View at Google Scholar · View at Scopus
  51. K. A. Kaltenbach and L. P. Finnegan, “Prenatal narcotic exposure: perinatal and developmental effects,” Neurotoxicology, vol. 10, no. 3, pp. 597–604, 1989. View at Google Scholar · View at Scopus
  52. H. M. E. Belcher, B. K. Shapiro, M. Leppert et al., “Sequential neuromotor examination in children with intrauterine cocaine/polydrug exposure,” Developmental Medicine and Child Neurology, vol. 41, no. 4, pp. 240–246, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Kaltenbach and L. P. Finnegan, “Neonatal abstinence syndrome, pharmacotherapy and developmental outcome,” Neurobehavioral Toxicology and Teratology, vol. 8, no. 4, pp. 353–355, 1986. View at Google Scholar · View at Scopus
  54. A. Van Baar, “Development of infants of drug dependent mothers,” Journal of Child Psychology and Psychiatry and Allied Disciplines, vol. 31, no. 6, pp. 911–920, 1990. View at Google Scholar · View at Scopus
  55. V. Moe, “Foster-placed and adopted children exposed in utero to opiates and other substances: prediction and outcome at four and a half years,” Journal of Developmental and Behavioral Pediatrics, vol. 23, no. 5, pp. 330–339, 2002. View at Google Scholar · View at Scopus
  56. A. Ornoy, J. Segal, R. Bar-Hamburger, and C. Greenbaum, “Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors,” Developmental Medicine and Child Neurology, vol. 43, no. 10, pp. 668–675, 2001. View at Google Scholar · View at Scopus
  57. J. L. Jacobson and S. W. Jacobson, “Prospective, longitudinal assessment of developmental neurotoxicity,” Environmental Health Perspectives, vol. 104, no. 2, pp. 275–283, 1996. View at Google Scholar · View at Scopus
  58. H. E. Jones, K. Kaltenbach, and K. E. O'Grady, “The complexity of examining developmental outcomes of children prenatally exposed to opiates. A response to the Hunt et al. Adverse neurodevelopmental outcome of infants exposed to opiates in-utero. Early Human Development (2008, 84, 29–35),” Early Human Development, vol. 85, no. 4, pp. 271–272, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. M. Levine, S. Walter, H. Lee, T. Haines, A. Holbrook, and V. Moyer, “Users' guides to the medical literature—4. How to use an article about harm,” Journal of the American Medical Association, vol. 271, no. 20, pp. 1615–1619, 1994. View at Publisher · View at Google Scholar
  60. R. Bunikowski, I. Grimmer, A. Heiser, B. Metze, A. Schäfer, and M. Obladen, “Neurodevelopmental outcome after prenatal exposure to opiates,” European Journal of Pediatrics, vol. 157, no. 9, pp. 724–730, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. D. D. Davis and D. I. Templer, “Neurobehavioral functioning in children exposed to narcotics in utero,” Addictive Behaviors, vol. 13, no. 3, pp. 275–283, 1988. View at Publisher · View at Google Scholar · View at Scopus
  62. M. M. De Cubas and T. Field, “Children of methadone-dependent women: developmental outcomes,” American Journal of Orthopsychiatry, vol. 63, no. 2, pp. 266–276, 1993. View at Google Scholar · View at Scopus
  63. X. Guo, J. W. Spencer, P. E. Suess, J. E. Hickey, W. E. Better, and R. I. Herning, “Cognitive brain potential alterations in boys exposed to opiates: in utero and lifestyle comparisons,” Addictive Behaviors, vol. 19, no. 4, pp. 429–441, 1994. View at Publisher · View at Google Scholar · View at Scopus
  64. M. H. Lifschitz, G. S. Wilson, E. O'Brian Smith, and M. M. Desmond, “Factors affecting head growth and intellectual function in children of drug addicts,” Pediatrics, vol. 75, no. 2, pp. 269–274, 1985. View at Google Scholar · View at Scopus
  65. B. M. Lester, E. Z. Tronick, L. LaGasse et al., “The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants,” Pediatrics, vol. 110, no. 6 I, pp. 1182–1192, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. D. S. Messinger, C. R. Bauer, A. Das et al., “The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age,” Pediatrics, vol. 113, no. 6 I, pp. 1677–1685, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. N. Ebner, K. Rohrmeister, B. Winklbaur et al., “Management of neonatal abstinence syndrome in neonates born to opioid maintained women,” Drug and Alcohol Dependence, vol. 87, no. 2-3, pp. 131–138, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  68. L. Jackson, A. Ting, S. Mckay, P. Galea, and C. Skeoch, “A randomized controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome,” Archives of Disease in Childhood, vol. 89, no. 4, pp. F300–F304, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. K. T. Khoo, The effectiveness of three treatment regimens used in the management of neonatal abstinence syndrome, Ph.D. thesis, University of Melbourne, 1995.
  70. M. G. Coyle, A. Ferguson, L. LaGasse, J. Liu, and B. Lester, “Neurobehavioral effects of treatment for opiate withdrawal,” Archives of Disease in Childhood, vol. 90, no. 1, pp. F73–F74, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. M. G. Coyle, A. Ferguson, L. Lagasse, W. Oh, and B. Lester, “Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants,” Journal of Pediatrics, vol. 140, no. 5, pp. 561–564, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. A. G. Agthe, G. R. Kim, K. B. Mathias et al., “Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial,” Pediatrics, vol. 123, no. 5, pp. e849–e856, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. A. Esmaeili, A. K. Keinhorst, T. Schuster, F. Beske, R. Schlösser, and C. Bastanier, “Treatment of neonatal abstinence syndrome with clonidine and chloral hydrate,” Acta Paediatrica, vol. 99, no. 2, pp. 209–214, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. J. B. Leikin, W. P. MacKendrick, G. E. Maloney et al., “Use of clonidine in the prevention and management of neonatal abstinence syndrome,” Clinical Toxicology, vol. 47, no. 6, pp. 551–555, 2009. View at Publisher · View at Google Scholar · View at PubMed